INTEGRA Biosciences’ products offer flexibility in the post-pandemic era

Many laboratories purchased pipetting solutions from INTEGRA Biosciences during the COVID-19 pandemic to help them cope with the high numbers of samples they were receiving every day for PCR testing. Now the pandemic has been brought somewhat under control, labs are once again able to concentrate their efforts on other vital work, but what has become of those pipetting platforms and devices?

A recent survey conducted by INTEGRA provides insights into how these systems are finding new uses now that they are no longer needed for COVID-19 testing.

Labs turned to INTEGRA pipetting systems – from VOYAGER adjustable tip spacing pipettes and VIAFLO lightweight electronic pipettes to VIAFLO 96 and VIAFLO 384 handheld electronic pipettesMINI 96 portable electronic pipettes and ASSIST PLUS pipetting robots – to automate and speed up their PCR workflows, thanks to the combination of ease of use, intuitive operation, and straightforward programming.

These same features are now allowing the instruments to be used in a range of new non-COVID applications, including DNA sequencing, antibiotic resistance investigations, women’s health testing, and the development of novel assays for high-prevalence diseases like monkeypox and STIs.

75% of the labs participating in the survey purchased an ASSIST PLUS. They chose this pipetting robot for greater flexibility through the automation of multichannel pipettes. The newly launched D-ONE single-channel pipetting module also allows the platform to perform tasks requiring only a single channel, effectively processing tedious tasks, such as serial dilutions, sample normalization, hit picking, or pipetting of complex plate layouts with minimal hands-on time.

The main benefit of automation with the ASSIST PLUS and the VOYAGER cited in the survey was the ability to reduce errors for greater consistency, accuracy, and reproducibility of results. In addition, automating laborious and time-consuming liquid transfer steps means that fewer staff are needed to process more specimens, enhancing lab throughput.

Based on these positive experiences, 92% of customers plan to use their pipetting robot for additional applications in the years to come – including allergy and infectious disease testing, pharmacogenomics, targeted genome sequencing and research into antimicrobial resistance – enhancing their workflows and ensuring they are adaptable to the diagnostic needs of the future.

Visit the INTEGRA Biosciences website to learn more.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    INTEGRA Biosciences. (2024, February 13). INTEGRA Biosciences’ products offer flexibility in the post-pandemic era. News-Medical. Retrieved on April 18, 2024 from https://www.news-medical.net/news/20230323/INTEGRA-Biosciencese28099-products-offer-flexibility-in-the-post-pandemic-era.aspx.

  • MLA

    INTEGRA Biosciences. "INTEGRA Biosciences’ products offer flexibility in the post-pandemic era". News-Medical. 18 April 2024. <https://www.news-medical.net/news/20230323/INTEGRA-Biosciencese28099-products-offer-flexibility-in-the-post-pandemic-era.aspx>.

  • Chicago

    INTEGRA Biosciences. "INTEGRA Biosciences’ products offer flexibility in the post-pandemic era". News-Medical. https://www.news-medical.net/news/20230323/INTEGRA-Biosciencese28099-products-offer-flexibility-in-the-post-pandemic-era.aspx. (accessed April 18, 2024).

  • Harvard

    INTEGRA Biosciences. 2024. INTEGRA Biosciences’ products offer flexibility in the post-pandemic era. News-Medical, viewed 18 April 2024, https://www.news-medical.net/news/20230323/INTEGRA-Biosciencese28099-products-offer-flexibility-in-the-post-pandemic-era.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Accelerating antibody therapy with INTEGRA pipettes